New York, NY, June 07, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Bioelectric Medicine Market By Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Retinal Implants, and Other Bioelectric Medicines), By Type (Implantable Electroceutical devices, Non-invasive Electroceutical Devices), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Epilepsy, Urinary, and Fecal Incontinence, and Others), By End User (Hospitals, and Diagnostic Centres), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026”.
“According to the recent research report, the demand of global Bioelectric Medicine Market size & share expected to reach to USD 36.79 Billion by 2026 from USD 23.31 Billion in 2020, at a compound annual growth rate (CAGR) of 7.9% during the forecast period 2021 to 2026”
Global Bioelectric Medicine Market: Overview
Bioelectric medicine refers to medical devices that use electrical pulses to modulate the neural circuits of the body as an alternative to drug-based intervention. Bioelectric medicine, are also popular as electroceuticals, is a branch of medicine that integrates bioengineering, molecular medicine, and neuroscience to discover and create nerve stimulation and sensing technologies to control biological processes and treat diseases. Bioelectric medicine is a field that integrates bioengineering, molecular medicine, and neuroscience to create nerve-stimulating devices for the control of biological processes during illness therapy. With the development of more complicated devices and innovative materials that have been developed down to the nanoscale, the bioelectric sector has been able to advance recently.
Request Your Free Sample Report of Global Bioelectric Medicine Market @ https://www.fnfresearch.com/sample/bioelectric-medicine-market
(The free sample of this report is readily available on request).
Our Free Sample Report Includes:
- 2020 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 195+ Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of table & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)
Industry Major Market Players
- Boston Scientific Corporation
- Medtronic plc
- Cochlear Limited
- Sonova Holding AG
- Biotronik
- ElectroCore LLC
- St. Jude Medical Inc.
- LivaNova plc
- Second Sight Medical Products Inc.
- Nevro Corporation
- MED-EL
- Cefaly Technology
- BioElectronics Corporation
- Vomaris Innovations Inc.
- EnteroMedics Inc.
- Stimwave LLC
- Oticon Medical
- NeuroSigma Inc.
To know an additional revised list of 2020-2021 top market players, request a sample report: https://www.fnfresearch.com/sample/bioelectric-medicine-market
Key questions answered in this report:
- What is the projected market size & growth rate of the Bioelectric Medicine Market?
- What are the key driving factors for the growth of the Bioelectric Medicine Market?
- What are the top companies operative in Bioelectric Medicine Market?
- What segments are covered in Bioelectric Medicine Market?
- How can I get free sample report/company profiles of the Bioelectric Medicine Market?
Market Dynamics
Rising Prevalence of Chronic Diseases
Rising cost pressures on drug-based medicines and growing interest from major pharmaceutical players in bioelectric medicine, and rising incidence and prevalence of neurological disorders and cardiac diseases around the world are some of the factors that are expected to drive the global bioelectric medicine market growth during the forecast period. According to the CDC, over 610 thousand individuals die in the United States each year as a result of heart disease. Around 370 persons die as a result of coronary heart disease (CHD). As a result, improved bioelectric medicine is in great demand for the treatment of various chronic illnesses, which is projected to drive market expansion. Major corporations like GlaxoSmithKline plc have made considerable investments in the bioelectric medicine industry, while other institutions such as the National Institutes of Health (NIH) in the United States have expressed strong interest in the subject.
Bioelectric medicine is a field that integrates bioengineering, molecular medicine, and neuroscience to create nerve-stimulating devices for the control of biological processes during illness therapy. Cardiovascular Diseases (CVDs) are a leading cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC). CVDs are likely to be the cause of one-fourth of all deaths. Stroke and IHD are the leading causes of CVD-related death, accounting for more than 80% of all deaths. Furthermore, by 2030, the economic cost of CVDs is expected to reach over USD 1,044 billion.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/bioelectric-medicine-market
Manufacturers' increasing R&D investments and the increasing rate of regulatory approvals for novel electroceuticals are two other important drivers driving the sector's growth. For example, the InterStim Smart Programmer was used with the InterStim System for sacral neuromodulation therapy in December 2018. Medtronic was the first to develop sacral neuromodulation, and this new device was intended to help the business expand its market share.
Government laws governing the development and manufacture of medical equipment such as cardiac pacemakers, implantable cardioverter defibrillators, and neuromodulation devices could stifle the bioelectric medicine market's growth. Prior to receiving a PMA, the devices must undergo extensive clinical testing, which increases the producers' expenses significantly. Furthermore, product recalls are a significant burden for manufacturers, and they may have a negative impact on the sector's growth.
Request Customized Copy of Report @ https://www.fnfresearch.com/customization/bioelectric-medicine-market
(We customize your report according to your research need. Ask our sales team for report customization.)
COVID-19 Impact on the Global Bioelectric Medicine Market
Drug and biotech organizations, as a team with governments all through the world, are attempting to battle the COVID-19 flare-up, from immunization examination to anticipating obstructions in the drug inventory network.
Furthermore, commonly used medications like Hydroxychloroquine have shown a significant increase in popularity for the treatment of COVID-19. The increased interest in COVID-19 administration prescriptions has provided a huge opportunity for architects of COVID-19 administration prescriptions, as many affluent countries are short on these pharmaceuticals. Because of the need for COVID-19 vaccines and treatment prescriptions, the pharmaceutical and biotechnology industries are expected to grow significantly in the future. Because of these considerations, Coronavirus - 19 is expected to have a significant impact on the electroceuticals/bioelectric medicines business.
Request COVID-19 Impact Analysis on Bioelectric Medicine Market @ https://www.fnfresearch.com/sample/bioelectric-medicine-market
Global Bioelectric Medicine Market: Segmentation
The global bioelectric medicine market is segregated into the product, type, application, and end-user. The products are categorized into implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators, retinal implants, and other bioelectric medicines. The implanted cardioverter defibrillators segment had dominated the global market owing to the significant use of these products for arrhythmia. In addition, expanding elderly population, increased incidence of abrupt cardiac arrests, and advanced product development is likely to drive market growth. Because of the rising frequency of Parkinson's disease and lifestyle-related illnesses such as obesity and depression, the deep brain stimulator market is predicted to rise significantly throughout the projected period. In terms of type, the market has been classified into implantable electroceutical devices and non-invasive electroceutical devices.
Asia Pacific Region Dominates the Global Bioelectric Medicine Market
In 2020, North America represented the largest share of the global bioelectric pharmaceutical market, accounting for roughly 41% of the total. In the same year, Europe accounted for around 28.0 percent of the total market, second only to North America. Growing demand for novel clinical devices for treatment, as well as the existence of large bioelectric drug manufacturers, primarily in Germany, Switzerland, the United Kingdom, and France, as well as a well-developed medical care framework, are expected to be major market drivers. Because of the aging population in Asian countries such as China and India, the Asia Pacific region is expected to have the highest CAGR of 8.5 percent over the projection period.
Browse the full report “Bioelectric Medicine Market By Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Retinal Implants, and Other Bioelectric Medicines), By Type (Implantable Electroceutical devices, Non-invasive Electroceutical Devices), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Epilepsy, Urinary, and Fecal Incontinence, and Others), By End User (Hospitals, and Diagnostic Centres), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026” report at https://www.fnfresearch.com/bioelectric-medicine-market
The global bioelectric medicine market is segmented as follows:
By Product:
- Implantable Cardioverter Defibrillators
- Cardiac Pacemakers
- Cochlear Implants
- Deep Brain Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators
- Retinal Implants
- Other Bioelectric Medicines
By Type:
- Implantable Electroceutical Devices
- Non-invasive Electroceutical Devices
By Application:
- Arrhythmia
- Pain Management
- Sensorineural Hearing Loss
- Parkinson’s Disease
- Tremor
- Depression
- Epilepsy
- Urinary and Fecal Incontinence
- Others
By End-user:
- Hospitals
- Diagnostic Centres
Key Highlights of this Report:
- Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
- Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
- Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
- Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
- Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
- Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
For media inquiry, mail to: sales@fnfresearch.com
About Facts & Factors (FnF Research):
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us Twitter: https://twitter.com/fnfresearch
Contact Us:
Facts & Factors
USA: +1-347-989-3985
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com
Blog: http://fnfnewsblog.com